120 related articles for article (PubMed ID: 2711992)
1. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
6. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
Nikkilä M; Inkovaara J; Heikkinen J
Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release diltiazem: duration of antihypertensive effect.
Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
[TBL] [Abstract][Full Text] [Related]
9. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
Pool PE; Seagren SC; Salel AF
Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
[TBL] [Abstract][Full Text] [Related]
10. Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.
Dupont AG; Coupez JM; Jensen P; Coupez-Lopinot R; Schoors DF; Hermanns P; Nicolas M
Cardiovasc Drugs Ther; 1991 Aug; 5(4):701-7. PubMed ID: 1888693
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Wolfson P; Abernethy D; DiPette DJ; Zusman R
Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
[TBL] [Abstract][Full Text] [Related]
15. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
[TBL] [Abstract][Full Text] [Related]
16. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
Whelton A; Eff J; Magner DJ
J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
[TBL] [Abstract][Full Text] [Related]
17. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study.
Neutel JM; Smith DH; Frishman WH
Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447
[TBL] [Abstract][Full Text] [Related]
18. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
Lacourcière Y; Poirier L; Boucher S; Spenard J
Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination.
Prisant LM;
Am J Ther; 2000 May; 7(3):177-84. PubMed ID: 11317166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]